The Ross and Carol Nese College of Nursing, in partnership with Penn State Health Milton S. Hershey Medical Center, hosted ...

SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

The poster presentations will be held on June 22, 2025, at the American Diabetes Association 85th Scientific Sessions in Chicago, IL. What is ACCG-2671 and its significance?

SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, June 19, 2025 /PRNewswire/ -- Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the presentation of key ...

Saol Therapeutics Announces Poster Presentation at the UMDF Mitochondrial Medicine 2025 Conference Provided by PR Newswire Jun 19, 2025, 4:30:00 AM ...

ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, June 19, 2025 /PRNewswire/ -- Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the presentation of key ...

Session Type: E-Poster Poster No.: 145eTiP About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer.

Co-authors from Penn Nursing include K. Jane Muir, PhD, MSHP, RN; Daniela Golinelli, PhD; and Ann Kutney-Lee, PhD, RN; Lee Ang from the University of Pennsylvania Mixed Methods Lab; and Kelvin ...

Details on the presentation can be found below. A copy of the Company's poster presentation will be available under the Scientific Presentations tab of the Tonix website at following the conference.